Cargando…
Erratum to: Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma
Autores principales: | Abe, T, Minami, K, Harabayashi, T, Sazawa, A, Chiba, H, Kikuchi, H, Miyata, H, Matsumoto, R, Osawa, T, Maruyama, S, IshizakiIshizaki, J, Mochizuki, T, Chiba, S, Akino, T, Murakumo, M, Miyajima, N, Tsuchiya, K, Murai, S, Shinohara, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284546/ https://www.ncbi.nlm.nih.gov/pubmed/32382760 http://dx.doi.org/10.1093/jjco/hyz196 |
Ejemplares similares
-
Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma
por: Abe, T, et al.
Publicado: (2019) -
Erratum: Prognostic impact of local radiotherapy on metastatic urothelial carcinoma patients receiving systemic chemotherapy
por: Abe, Takashige, et al.
Publicado: (2020) -
Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan
por: Matsumoto, Ryuji, et al.
Publicado: (2018) -
Diagnostic outcome of ureteroscopy in urothelial carcinoma of the upper urinary tract: Incidence of later cancer detection and its risk factors after the first examination
por: Murahashi, Norihiro, et al.
Publicado: (2015) -
Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection
por: Abe, Takashige, et al.
Publicado: (2018)